Cytodyn Inc (CYDY)

[MelsDollars]

I've been invested in pre-revenue biotech before and this "management must be replaced" argument is right out of the big pharma buyout playbook. If you're a big pharma company and there's a small biotech company with a promising drug, and you want to buy them, but there's a management team in place that's savvy enough to know how much it's worth, big pharma will work to discredit management, erode shareholder confidence and then use them to vote to replace management. Then in strolls a new CEO more friendly to big pharma and a buyout will be immediately announced at a much lower price than expected.

Sorry, I'd much rather keep Dr. Pourhassan and Kelly. In my opinion, they care about the drug, the patients and about shareholder value.